Joseph Loscalzo, Director at IONIS PHARMACEUTICALS INC (IONS), sold 77,289 shares at $74.90 ($5.8M) on 2026-05-04, disclosed to the SEC on 2026-05-06.
Scheduled sale ($5.8M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.90 | 59,508 | $4.5M | 76.8% |
| 2 | $75.58 | 17,781 | $1.3M | 23.2% |
| Total | $75.06 avg | 77,289 | $5.8M | 100% |
| Filing → |
| IONS | SELL | 2025-09-04 | $962K | — | Filing → |
| IONS | SELL | 2024-11-14 | $1.0M | — | Filing → |